TR200200313T2 - Hızla çözünen dozaj formu ve bunun yapım prosesi. - Google Patents

Hızla çözünen dozaj formu ve bunun yapım prosesi.

Info

Publication number
TR200200313T2
TR200200313T2 TR2002/00313T TR200200313T TR200200313T2 TR 200200313 T2 TR200200313 T2 TR 200200313T2 TR 2002/00313 T TR2002/00313 T TR 2002/00313T TR 200200313 T TR200200313 T TR 200200313T TR 200200313 T2 TR200200313 T2 TR 200200313T2
Authority
TR
Turkey
Prior art keywords
dosage form
production process
rapidly dissolving
dissolving dosage
dosage forms
Prior art date
Application number
TR2002/00313T
Other languages
English (en)
Inventor
Martani Rose
Original Assignee
Novartis Consumer Health S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Consumer Health S.A. filed Critical Novartis Consumer Health S.A.
Publication of TR200200313T2 publication Critical patent/TR200200313T2/tr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Mevcut bulus,sulu ortamda hizla çözünen kati bir dozaj formu ile ilgilidir. özellikle bulus agiz içerisinde hizla eriyecek/çözünecek sekilde tasarlanan,oral yolla alinan farmasötik kati dozaj formlari ve veterinerlige iliskin benzer dozaj formlari ile ilgilidir. Ayrica bulus, bahsedilen kati dozaj formlarinin üretimi için benzersiz bir proses saglamaktadir.
TR2002/00313T 1999-08-17 2000-08-14 Hızla çözünen dozaj formu ve bunun yapım prosesi. TR200200313T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99810738 1999-08-17

Publications (1)

Publication Number Publication Date
TR200200313T2 true TR200200313T2 (tr) 2002-04-22

Family

ID=8242980

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/00313T TR200200313T2 (tr) 1999-08-17 2000-08-14 Hızla çözünen dozaj formu ve bunun yapım prosesi.

Country Status (8)

Country Link
US (1) US7182959B2 (tr)
EP (1) EP1202716A1 (tr)
JP (1) JP2003506480A (tr)
AU (1) AU765526B2 (tr)
CA (1) CA2380449A1 (tr)
HK (1) HK1046236A1 (tr)
TR (1) TR200200313T2 (tr)
WO (1) WO2001012161A1 (tr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060073188A1 (en) * 1999-03-31 2006-04-06 Pierre Fabre Medicament Fast-dissolving isotropic expanded microporous composition or structure for pharmaceutical, veterinary, dietetic, food or cosmetic use and method for obtaining same
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
AR034813A1 (es) * 2001-07-20 2004-03-17 Novartis Ag Composiciones farmaceuticas y uso de las mismas
WO2003013470A1 (en) * 2001-08-09 2003-02-20 Smithkline Beecham Plc. Composition comprising paroxetine and a pharmaceutically acceptable glycyrrhizinate salt
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
EP1485296B1 (en) * 2002-02-13 2011-07-20 Michael K. Weibel Drug dose - form and method of manufacture
ES2199061B1 (es) * 2002-06-10 2005-02-16 Laboratorios Vita, S.A. Comprimidos bucodispersables y procedimiento para su obtencion.
JP4320217B2 (ja) * 2002-07-10 2009-08-26 剤盛堂薬品株式会社 鼻炎用経口製剤
US8992980B2 (en) * 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
US20070092583A1 (en) * 2003-04-30 2007-04-26 Tim Clarot Cold remedy composition comprising zinc salts
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
US20050214365A1 (en) * 2004-03-24 2005-09-29 Gulf Pharmaceutical Industries [Instant dissolving tablet composition for loratidine and desloratidine]
US8101244B2 (en) * 2004-06-09 2012-01-24 Smithkline Beecham Corporation Apparatus and method for producing or processing a product or sample
US20060002594A1 (en) * 2004-06-09 2006-01-05 Clarke Allan J Method for producing a pharmaceutical product
TWI428271B (zh) * 2004-06-09 2014-03-01 Smithkline Beecham Corp 生產藥物之裝置及方法
PE20060935A1 (es) * 2004-10-21 2006-10-26 Novartis Ag Composicion farmaceutica que comprende diclofenaco
JP4980228B2 (ja) * 2004-10-28 2012-07-18 パンテック・アーゲー 高度に多孔質の急速崩壊性固体剤形および粉末の調製および凍結乾燥工程を含むその製造方法
EP2101739A2 (en) * 2006-12-21 2009-09-23 Mallinckrodt Inc. Composition of and method for preparing orally disintegrating tablets containing a high dose of pharmaceutically active ingredients
EP2170282A4 (en) * 2007-06-27 2014-11-05 Hanmi Pharm Ind Co Ltd METHOD FOR PRODUCING A QUICKLY CRUSHING FORMULATION FOR ORAL ADMINISTRATION AND DEVICE FOR PREPARING AND PACKAGING THE FORMULATION
US20100190739A1 (en) * 2008-12-15 2010-07-29 Fleming And Company, Pharmaceuticals Rapidly Dissolving Vitamin Formulation and Methods of Using the Same
US8859003B2 (en) * 2009-06-05 2014-10-14 Intercontinental Great Brands Llc Preparation of an enteric release system
US20100307542A1 (en) * 2009-06-05 2010-12-09 Kraft Foods Global Brands Llc Method of Reducing Surface Oil on Encapsulated Material
US20100310726A1 (en) 2009-06-05 2010-12-09 Kraft Foods Global Brands Llc Novel Preparation of an Enteric Release System
US9968564B2 (en) 2009-06-05 2018-05-15 Intercontinental Great Brands Llc Delivery of functional compounds
AU2010284028A1 (en) * 2009-08-17 2012-03-29 Waxtabs (Pty) Ltd Process for manufacturing tablets by using a fluent and settable matrix, and tablets obtained therewith
US12186426B2 (en) 2009-10-30 2025-01-07 Ix Biopharma Ltd. Solid dosage form
US20110105441A1 (en) * 2009-10-30 2011-05-05 Fmc Corporation Stable Orally Disintegrating Tablets Having Low Superdisintegrant
TR201902233T4 (tr) 2009-10-30 2019-03-21 Ix Biopharma Ltd Hızlı çözünen katı dozaj formu.
WO2011087705A2 (en) * 2009-12-22 2011-07-21 Fmc Corporation Fine particle croscarmellose and uses thereof
MX341200B (es) 2010-03-29 2016-08-11 Ferring Bv Composicion farmaceutica de disolucion rapida.
JO3112B1 (ar) * 2010-03-29 2017-09-20 Ferring Bv تركيبة دوائية سريعة التحلل
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
US20150064263A1 (en) * 2010-05-25 2015-03-05 David Kossor Compositions and methods for reduction of mercury toxicity
BR112014005134A2 (pt) 2011-09-16 2017-04-18 Ferring Bv composição farmacêutica de dissolução rápida
US8859005B2 (en) 2012-12-03 2014-10-14 Intercontinental Great Brands Llc Enteric delivery of functional ingredients suitable for hot comestible applications
US9907323B2 (en) 2015-09-25 2018-03-06 Mead Johnson Nutrition Co. Infant formula tablets

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4311490A (en) * 1980-12-22 1982-01-19 General Electric Company Diamond and cubic boron nitride abrasive compacts using size selective abrasive particle layers
ATE24964T1 (de) * 1981-12-11 1987-01-15 Wyeth John & Brother Ltd Verfahren zur herstellung von festen formgegenstaenden.
HU203041B (en) * 1989-03-14 1991-05-28 Egyt Gyogyszervegyeszeti Gyar Process for producing pharmaceutical compositions of controlled releasing factor containing nifedipin
AU639988B2 (en) * 1990-04-11 1993-08-12 Pharmacia & Upjohn Company Taste masking of ibuprofen by fluid bed coating
DK0587744T3 (da) * 1991-05-28 2003-10-20 Mcneil Ppc Inc Tygbar sammensætning til frigørelse af et lægemiddel
ATE172637T1 (de) * 1991-12-24 1998-11-15 Yamanouchi Pharma Co Ltd Intrabukkal desintegrierende zubereitung und ihre herstellung
US5686107A (en) * 1995-01-30 1997-11-11 Fmc Corporation Chewable pharmaceutical tablets
WO1997038679A2 (en) * 1996-04-16 1997-10-23 Novartis Consumer Health S.A. Fast disintegrating oral dosage form
EP0839526A3 (en) * 1996-10-31 1999-01-07 Takeda Chemical Industries, Ltd. Solid pharmaceutical preparation with fast buccal disintegration or dissolution
US5904937A (en) * 1997-10-03 1999-05-18 Fmc Corporation Taste masked pharmaceutical compositions
JPH11116466A (ja) * 1997-10-09 1999-04-27 Ss Pharmaceut Co Ltd 急速溶解型固形製剤およびその製造法
US6194395B1 (en) * 1999-02-25 2001-02-27 Orthro-Mcneil Pharmaceutical, Inc. Cyclodextrin cladribine formulations

Also Published As

Publication number Publication date
JP2003506480A (ja) 2003-02-18
HK1046236A1 (zh) 2003-01-03
CA2380449A1 (en) 2001-02-22
US7182959B2 (en) 2007-02-27
WO2001012161A1 (en) 2001-02-22
AU7275700A (en) 2001-03-13
EP1202716A1 (en) 2002-05-08
US20020131998A1 (en) 2002-09-19
AU765526B2 (en) 2003-09-18

Similar Documents

Publication Publication Date Title
HK1046236A1 (zh) 迅速溶解的剂量形式及其生产方法
DE60100186D1 (de) Orale pharmazeutische formulierungen von benzimidazolderivaten und verfahren zu ihrer herstellung
ATE252562T1 (de) Pyrazolcarbonsäurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
ATE495154T1 (de) Pharmazeutische zusammensetzungen, die ccr5- antagonisierende piperazinderivate enthalten
CY2016024I2 (el) ΔΙΑΛΥΤΗ ΓΛΥΚΟΠΡΩΤΕΪΝΗ ΥΑΛΟΥΡΟΝΙΔΑΣΗΣ (sHASEGP), ΔΙΑΔΙΚΑΣΙΑ ΓΙΑ ΤΗΝ ΠΑΡΑΣΚΕΥΗ ΤΗΣ, ΧΡΗΣΕΙΣ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΣΥΝΘΕΣΕΙΣ ΠΟΥ ΤΗΝ ΠΕΡΙΛΑΜΒΑΝΟΥΝ
ATE478840T1 (de) 3-aminoazetidinderivate enthaltende pharmazeutische zusammensetzungen, diese derivate und deren herstellung
EE05104B1 (et) Asetidiini derivaadid, nende valmistamise meetodid ja farmatseutiline kompositsioon
EE04464B1 (et) Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
ES2177346T3 (es) Formulaciones de ranolazina de liberacion lenta.
ATE196422T1 (de) Schnellauflösliche pharmazeutische dosierungsformen und verfahren zu ihrer herstellung
TR199802139T2 (tr) Sisaprid'in aninda tahliye saglayan, PH'dan bagimsiz kati dozaj sekli.
ATE245152T1 (de) Dioxocyclopentylhydroxamsäure
HUP0300896A3 (en) Beta-amino acid nitrile derivatives, process for their preparation and pharmaceutical compositions containing them
IS5851A (is) Ný lyf til inntöku 5-HT4 gerandefna eða mótlyfja
DE60022188D1 (de) Amorphe salpetersäureester und deren pharmazeutische zusammensetzungen
ATE323092T1 (de) Pyridopyrimidinon-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
BR0008228A (pt) Composições de n-benzoil estaurosporinaespontaneamente dispersìveis
BR0015256A (pt) Composições farmacêuticas contendo uma droga de antibiótico de fluoroquinolona e uma goma de xantano
PA8579801A1 (es) Composiciones farmaceuticas de farmacos semiordenados y polimeros
ATE290858T1 (de) N-palmitoylethanolamid-enthaltende pharmazeutische zusammensetzungen und deren verwendung in der veterinärmedizin
EA200400061A1 (ru) Фармацевтический состав с замаскированным вкусом и способ его получения
UA90893C2 (ru) Пероральная дозированная форма производных гемцитабина
ATE222586T1 (de) Benzolsulfonamidderivate und verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
FR2804024B1 (fr) Nouvelles compositions pharmaceutiques a action anti- inflammatoire et leur procede de preparation
DE60004204D1 (de) Pharmazeutische zusammensetzungen, bestimmt zur oralen verabreichung von phloroglucinol sowie deren herstellung